Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Condensed ring based ketone derivatives, preparation method thereof and application of derivatives in medicine

A technology of heterocyclyl and cycloalkyl, which can be used in the field of TLR7 agonists to solve problems such as side effects

Active Publication Date: 2018-11-13
JIANGSU HENGRUI MEDICINE CO LTD +1
View PDF11 Cites 16 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Interferon α is one of the main drugs for the treatment of chronic hepatitis B or C, while TNF-α is a pro-inflammatory cytokine, excessive secretion may lead to serious side effects

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Condensed ring based ketone derivatives, preparation method thereof and application of derivatives in medicine
  • Condensed ring based ketone derivatives, preparation method thereof and application of derivatives in medicine
  • Condensed ring based ketone derivatives, preparation method thereof and application of derivatives in medicine

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0260] 5-Amino-7-butoxy-1-(4-(pyrrolidin-1-ylmethyl)benzyl)pyrimido[4,5-d]pyrimidin-2(1H)-one

[0261]

[0262]

[0263] first step

[0264] 2-Butoxy-4,6-dichloropyrimidine-5-carbaldehyde 1b

[0265] Dissolve phosphorus oxychloride (6.24g, 0.0407mol) in 75mL tetrahydrofuran, cool to 0°C, add N,N-dimethylformamide (2.98g, 0.0407mol), stir for 1 hour, then add 2- Butoxypyrimidine-4,6-diol 1a (5 g, 0.0271 mol, prepared by the method disclosed in the patent application "US20160075707") was stirred for 30 minutes, then raised to room temperature and stirred for 16 hours. The reaction solution was concentrated under reduced pressure, 50 mL of phosphorus oxychloride was added, cooled to 0°C, N,N-diisopropylethylamine (6.99 g, 0.0542 mol) was added, the temperature was raised to 60°C and the reaction was stirred for 2 hours. The reaction solution was cooled to room temperature, concentrated under reduced pressure, 50 mL of water was added to the resulting residue, extracted wi...

Embodiment 2

[0285] 4-Amino-2-butoxy-8-(4-(pyrrolidin-1-ylmethyl)benzyl)pyrido[2,3-d]pyrimidin-7(8H)-one

[0286]

[0287]

[0288] first step

[0289] 4-(bis(4-methoxybenzyl)amino)-2-butoxy-6-((4-(pyrrolidin-1-ylmethyl)benzyl)amino)pyrimidine-5-carbaldehyde 2b

[0290] Compound 1c (200mg, 0.425mmol) was dissolved in 10mL N,N-dimethylformamide, and (4-(pyrrolidin-1-ylmethyl)phenyl)methanamine 2a (121.5mg, 0.638mmol, Prepared by the known method "Journal of Medicinal Chemistry, 2012, 55(23), 10387-10404") and potassium carbonate (118mg, 0.85mmol), heated to 40°C and stirred for 2 hours. The reaction solution was cooled to room temperature, ethyl acetate was added, washed with saturated sodium chloride solution, the organic phase was dried over anhydrous sodium sulfate, filtered, the filtrate was concentrated under reduced pressure, and the obtained residue was purified with eluent system A by a CombiFlash rapid preparation apparatus , to obtain the title compound 2b (230 mg, yield: ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to condensed ring based ketone derivatives, a preparation method thereof and an application of the derivatives in medicine, in particular to the new condensed ring based ketone derivatives shown as the general formula (I) in the description, the preparation method of the derivatives, pharmaceutical composition containing the derivatives and the application of the derivative as a therapeutic agent, especially a TLR7 (toll-like receptor 7) agonist. Substituent groups in the general formula (I) are defined as the description.

Description

technical field [0001] The invention belongs to the field of medicine, and relates to a new fused ring-based ketone derivative represented by general formula (I), its preparation method, a pharmaceutical composition containing the derivative and its use as a therapeutic agent, especially as a TLR7 agonist use of the agent. Background technique [0002] Toll-like receptors (toll-like receptors; TLRs) are an important class of protein molecules involved in innate immunity. TLRs are monomeric transmembrane non-catalytic receptors, usually expressed in sentinel cells such as macrophages and dendritic cells, which can recognize structurally conserved molecules produced by microorganisms. Once these microorganisms break through physical barriers such as skin or intestinal mucosa, they are recognized by TLRs, which in turn activate immune cell responses (Mahla, R S. et al., Front Immunol. 4:248 (2013)). The ability of the immune system to widely recognize pathogenic microorganism...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07D487/04C07D471/04A61P31/18A61P31/12A61P31/14A61P35/00A61P31/16A61P11/06A61P11/02A61P1/16A61P1/04
CPCA61P1/04A61P1/16A61P11/02A61P11/06A61P31/12A61P31/14A61P31/16A61P31/18A61P35/00C07D471/04C07D487/04Y02P20/55
Inventor 张国宝陈友喜黄智明贺峰陶维康
Owner JIANGSU HENGRUI MEDICINE CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com